CoChat
Sign Up
Cited by 44

The DOI matches its Crossref record.

Life and Death in Cancer GADD45 α and γ are Critical Regulators of NF- κB Mediated Escape from Programmed Cell Death

Zerbini, Luiz F., Libermann, Towia A.·2005·Cell Cycle
DOI 10.4161/cc.4.1.1363
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4161/cc.4.1.1363

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 23

  1. Li Q, Verma IM. NF-κB regulation in the immune system. Nat Rev Immunol 2002; 2:725-34.
  2. Karin M, Cao Y, Greten FR, Li ZW. NF-κB in cancer: From innocent bystander to major culprit. Nat Rev Cancer 2002; 2:301-10.
  3. Chauhan D, Uchiyama H, Akbarali Y, Urashima M, Yamamoto K, Libermann TA, Anderson KC. Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-κ B. Blood 1996; 87:1104-12.
  4. Oya M, Takayanagi A, Horiguchi A, Mizuno R, Ohtsubo M, Marumo K, Shimizu N, Murai M. Increased nuclear factor-κB activation is related to the tumor development of renal cell carcinoma. Carcinogenesis 2003; 24:377-84.
  5. Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription fac- tor NF-κB. J Clin Inves 2001; 107:241-6.
  6. De Martin R., Schmid JA, Hofer-Warbinek R. The NF-κB/Rel family of transcription fac- tors in oncogenic transformation and apoptosis. Mutat Res 1999; 437:231-43.
  7. Ghosh S, May MJ, Kopp EB. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16:225-60.
  8. Grilli M, Memo M. Nuclear factor-κB/Rel proteins: A point of convergence of signalling pathways relevant in neuronal function and dysfunction. Biochem Pharmacol 1999; 57:1-7.
  9. Zerbini LF, Wang Y, Cho JY, Libermann TA. Constitutive activation of nuclear factor κB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Cancer Res 2003; 63:2206-15.
  10. Stoffel A, Levine AJ. Actvation of NF-κB by the API2/MALT1 fusions inhibits p53 depen- dant but not FAS induced apoptosis: A directional link between NF-κB and p53. Cell Cycle 2004; 8:1017-20.
  11. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-B. Nature 1995; 376:167-9.
  12. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-alpha-induced apoptosis by NF-κB. Science 1996; 274:787-9.
  13. Liu ZG, Hu H, Goeddel DV, Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 1996; 87:565-76.
  14. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, Davis RJ. Requirement of JNK for stress-induced activation of the cytochrome c- mediated death pathway. Science 2000; 288: 870-4.
  15. Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z, Kolesnick RN. Requirement for ceramide- initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996; 380: 75-9.
  16. Tang G, Minemoto Y, Dibling B, Purcell NH, Li Z, Karin M, Lin A. Inhibition of JNK activation through NF-kappaB target genes. Nature 2001; 414: 313-7.
  17. Hall PA, Kearsey JM, Coates PJ, Norman DG, Warbrick E, Cox LS. Characterisation of the interaction between PCNA and Gadd45. Oncogene 1995; 10:2427-33.
  18. Chen IT, Akamatsu M, Smith ML, Lung FD, Duba D, Roller PP, Fornace Jr AJ and O'Connor PM.. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction. Oncogene 1996; 12: 595-607.
  19. De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J, Cong R, Franzoso G. Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature 2001; 15: 308-13.
  20. Amanullah A, Azam N, Balliet A, Hollander C, Hoffman B, Fornace A, Liebermann D. Cell signalling: cell survival and a Gadd45-factor deficiency. Nature 2003; 14: 741.
  21. Mita H, Tsutsui J, Takekawa M, Witten EA, Saito H. Regulation of MTK1/MEKK4 kinase activity by its N-terminal autoinhibitory domain and GADD45 binding. Mol Cell Biol 2002; 22:4544-55.
  22. Bubici C, Papa S, Pham CG, Zazzeroni F, Franzoso G. NF-κB and JNK: An intricate affair. Cell Cycle 2004; In press. 23.
  23. Zerbini LF, Wang Y, Czibere A, Correa RG, Cho JY, Ijiri K, Wei W, Joseph M, Gu X, Grall F, Goldring MB, Zhou JR, Libermann TA. NF-κB mediated repression of GADD45α and γ is essential for cancer cell survival. Proc Natl Acad Sci USA 2004; 101:13618-23.

Cited by

Metadata

Authors
Zerbini, L. F., & Libermann, T. A.
Venue
Cell Cycle
Publisher
Informa UK Limited
Published
2004-10-28
Volume
4
Issue
1
Pages
18-20
ISSN
  • 1538-4101
  • 1551-4005
DOI
10.4161/cc.4.1.1363
Cited by
44
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review